Stock OSSD OSSDSIGN AB
Add to a list
To use this feature you must be a member
Log inSign up

All News OssDsign AB

Equities

OSSD

SE0012570448

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:48 2024-04-29 am EDT 		5-day change 1st Jan Change
9.75 SEK +5.52% Intraday chart for OssDsign AB +4.39% +21.88%
Apr. 15 Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 15-APR-2024. CI
Apr. 02 OssDsign Signs Three-year Supply Contract with Premier for Bone, Bone Substitute Products MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
OssDsign expands military access with new contract covering 100 additional VA orthopedic hospitals
AQ
Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 15-APR-2024.
CI
OssDsign: Another quarter of triple-digit Catalyst growth expected
AQ
OssDsign Signs Three-year Supply Contract with Premier for Bone, Bone Substitute Products
MT
OssDsign awarded long-term agreement with Premier, Inc.
AQ
OssDsign AB Wins Long-Term Agreement with Premier, Inc
CI
OssDsign: Update after HC seminar and news in the spinal fusion market
AQ
Sweden's OssDsign Names Chief Technical Officer
MT
OssDsign appoints Tom Buckland as Chief Technical Officer
AQ
OssDsign AB (publ.) Appoints Tom Buckland as Chief Technical Officer
CI
OssDsign: Restructuring completed, focus on 2024
AQ
Transcript : OssDsign AB, Q4 2023 Earnings Call, Feb 06, 2024
OssDsign AB (publ) publishes year-end report 2023
AQ
OssDsign AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
OssDsign AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
OssDsign: Right time to fuse the spine
AQ
12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research
AQ
OssDsign AB (publ.) Announces 12-Month Data from the Clinical Study Top Fusion
CI
OssDsign reports exceptional data from the clinical study TOP FUSION
AQ
OssDsign AB Reports Exceptional Data from the Clinical Study TOP FUSION
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OSSD Stock
  4. News OssDsign AB